États-Unis · Bourse & Finance · Yahoo Finance

Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830

Publié par Yahoo Finance · États-Unis il y a 8 h

No. 21 / 2026 Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830 ZP9830 is a novel…

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830

À lire aussi

Japanese Prime Minister Takaichi rejects criticism around weak yen and high interest rates

China’s economy grew 4.5% last quarter, yet its export boom risks being ‘a drag on world growth’

XRP Ledger is set to fix its lending code before anyone can use it

Chaos and looting roiled major cities as Europeans poured into the streets to protest rising living costs

Asian markets mixed as technology selloff lifts Wall Street volatility

Strong Exports Stabilize China’s Economic Growth in Official Statistics

Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830

Partager

À lire aussi

Japanese Prime Minister Takaichi rejects criticism around weak yen and high interest rates

China’s economy grew 4.5% last quarter, yet its export boom risks being ‘a drag on world growth’

XRP Ledger is set to fix its lending code before anyone can use it

Chaos and looting roiled major cities as Europeans poured into the streets to protest rising living costs

Asian markets mixed as technology selloff lifts Wall Street volatility

Strong Exports Stabilize China’s Economic Growth in Official Statistics